Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-22

Clinical Trial Update: Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether artemisinin-based combination therapy together with quinine affects treatment failure and resistance in uncomplicated malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (artemisinin-based combination therapy)
  • Quinine (quinine)

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Malaria | Phase 3 | Status: COMPLETED